Presenter: Hans Jeppsson, CFO Presentation Date and Time: November 26 at 10:15 AM ET/4:15 PM CET
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
Report on the ATTRACT study
Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Patient insights to shape development of a dCBT for IPF patients
C21 shows promise against COVID-19 where other drugs have failed